Ekkasit TharavichitkulVicharn LorvidhayaImjai ChitapanarauxPimkhuan KamnerdsupaphonSomsak WanwilairatVimol Sukthomya2011-02-162011-02-162011-01-252011-01-25Chiang Mai Medical Journal; Vol.48 No.4 March 2009 (pages 125-159); 151 - 157http://imsear.searo.who.int/handle/123456789/130625Objectives Materials and methods fi ve had boost treatment after external irradiation. Aftertreatment was completed, the patients were appointed to attend a follow-up program toevaluate results and toxicities.Results fi stula, due to tumour progression.Conclusions fi t and gain of the patients. Chiang Mai MedicalJournal 2009;48(4):151-157.Interstitial brachytherapy can be used as an option to irradiate patients andboost treatment. However re-irradiation with brachytherapy should be critically evaluatedfor toxicities and local control for the beneAt the median follow up of 5 months, Three patients (23%) yielded good localcontrol. One patient developed vesico-vaginalFrom January 2007 to December 2008, thirteen patients withgynaecological cancers were treated by interstitial brachytherapy. Eight patients wererecurrent after irradiation andTo report the results of interstitial brachytherapy (ISBT) in gynaecologicalcancers.en-USChiang Mai Medical JournalCase Reports